Schweiger Dermatology Group

Based in the US, Schweiger Dermatology Group offers a wide array of dermatological services, focusing on both medical and cosmetic treatments, to cater to diverse skincare needs across multiple states. Schweiger Dermatology Group provides specialized dermatological care, including medical and cosmetic services. Founded in 2010, the firm is headquartered in New York, US, and has expanded across several states including New Jersey, Pennsylvania, Connecticut, Florida, Minnesota, Illinois, Missouri, and California. The company was co-founded by David Kriegel, Eric Schweiger, and Stephen Dagg, with Eric Schweiger serving as the CEO.

In January 2019, the firm raised USD 100. 00 mn in a funding round led by LNK Partners, bringing the total amount raised to USD 100. 00 mn. The firm has participated in 7 deals to date.

Schweiger Dermatology Group specializes in a comprehensive range of dermatological services, catering to both medical and cosmetic needs. Their core offerings include medical dermatology for diagnosing and treating conditions such as acne, eczema, and psoriasis, alongside cosmetic services like Botox, dermal fillers, and skin rejuvenation treatments. The firm emphasizes skin cancer treatments, focusing on early detection and comprehensive care through advanced methodologies, serving a diverse clientele seeking therapeutic and aesthetic solutions for their skin concerns. The revenue model for Schweiger Dermatology Group is based on direct patient interactions, with transactions primarily through health insurance reimbursements and out-of-pocket payments for non-covered services.

The company offers consultations, ongoing treatment plans, and cosmetic procedures, each priced according to service complexity. Medical dermatology consultations are billed at standard fees, while cosmetic procedures such as Botox and laser treatments are priced per session, accepting most insurances to facilitate access for patients and ensuring a streamlined billing process. In January 2019, Schweiger Dermatology Group raised USD 100. 00 mn in venture debt financing led by Crestline Investors.

The firm plans to utilize these funds for the development of new products and services and for expansion into new markets. Specific geographic regions targeted for expansion include additional states within the US, although exact locations and timelines were not disclosed.